Approval · Notice of Compliance 5585 · 1994
OSTAC: Notice of Compliance 5585
Issued November 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5585
- Date
- November 9, 1994
- Company
- Boehringer Mannheim (Canada) LteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OSTAC | Not yet assigned | — |
Medicinal ingredients
- CLODRONATE DISODIUM 400 MG per CAP
- CLODRONATE DISODIUM 30 MG per ML